Author: Kevin Grogan

The British Medical Association has called for the UK government to have less of a say in the day-to-day running of the National Health Service in England.

Days after a critical TV documentary on the drug, two new large studies have confirmed an increased incidence of death and kidney damage among patients given Bayer’s currently-suspended blood loss agent Trasylol.

Scotland’s Ardana Biosciences, which specialises in reproductive health products, says that its cash position is such that it is now seeking a buyer or merger partner to fund drug development.

Italy’s Recordati has been boosted by the news that Zan-Extra has been approved in Australia and the firm is getting ready for a Europe-wide launch for the new hypertensive.

UK biotechnology firm Vernalis is to cut over half its workforce as part of an extensive restructuring brought on by the rejection last year by US regulators of a supplementary filing for the migraine drug Frova.